Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IVERIC bio, Inc. - Common Stock (NQ:ISEE)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 10, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about IVERIC bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
7 Cheap Biotech Stocks to Buy Now ↗
These cheap biotech stocks to buy offer investors a way to get ready for the inevitable comeback in the biopharmaceutical sector. 
Via InvestorPlace
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022 ↗
Upgrades 
Via Benzinga
News headline image
What 5 Analyst Ratings Have To Say About IVERIC bio ↗
Within the last quarter, IVERIC bio (NASDAQ:ISEE) has observed the following analyst ratings: 
Via Benzinga
News headline image
IVERIC bio Shares Jump On Debt Financing To Fund Zimura Launch ↗
 
Via Benzinga
News headline image
Recap: IVERIC bio Q2 Earnings ↗
  IVERIC bio (NASDAQ:ISEE) reported its Q2 earnings results on Tuesday, July 26, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Earnings Scheduled For July 26, 2022 ↗
Companies Reporting Before The Bell • General Motors (NYSE:GM) is likely to report quarterly earnings at $1.30 per share on revenue of $34.59 billion. 
Via Benzinga
News headline image
Short Volatility Alert: IVERIC bio, Inc. ↗
On Wednesday, shares of IVERIC bio, Inc. (NASDAQ: ISEE) experienced volatile short activity. After the activity, the stock price went up +1.70% to $11.95. The overall sentiment for ISEE has been... 
Via Benzinga
News headline image
3 Biotech Stock Picks From This Wedbush Analyst ↗
While the S&P 500 index peaked in January and has had a rough year, the biotech sector peaked last August. For the time being, both have found a short-term and possible long-term bottom in June. 
Via Benzinga
News headline image
Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Alibaba, General Electric And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗
Redbox Entertainment Inc. (NASDAQ: RDBX) rose 11.5% to $6.19 in pre-market trading after jumping 82% on Monday. 
Via Benzinga
News headline image
Earnings Preview: IVERIC bio ↗
IVERIC bio (NASDAQ:ISEE) is set to give its latest quarterly earnings report on Tuesday, 2022-07-26. Here's what investors need to know before the announcement. Analysts estimate that IVERIC bio will... 
Via Benzinga
News headline image
Expert Ratings for IVERIC bio ↗
IVERIC bio (NASDAQ:ISEE) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
The Daily Biotech Pulse: AstraZeneca Goes Shopping, TYME Technologies & Syros Pharma Merger, FDA Clears Vertex Pharma's Stem Cell-Based Diabetes Therapy Study ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 8, 2022 ↗
Upgrades 
Via Benzinga
News headline image
IVERIC bio: Q1 Earnings Insights ↗
IVERIC bio (NASDAQ:ISEE) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings IVERIC bio reported in-line EPS of... 
Via Benzinga
News headline image
IVERIC bio Earnings Conference Call Is Coming Up, Here's What You Need To Know ↗
IVERIC bio (NASDAQ:ISEE) will host a conference call at 08:00 AM ET on May 4, 2022, to discuss Q1 2022 earnings results. How to Attend IVERIC bio (ISEE) Conference Call Follow this link to access the... 
Via Benzinga
News headline image
These Are Ten Small Cap Stocks With Strong Buy Recommendations ↗
One can reduce some risk by taking into account analyst recommendations. Stocks with strong buy recommendations are more likely to perform better than others. Let’s take a look at ten small cap stocks... 
Via Talk Markets
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 22, 2022 ↗
Upgrades For Procter & Gamble Co (NYSE:PG), Truist Securities upgraded the previous rating of Hold to Buy. For the second quarter, Procter & Gamble had an EPS of $1.66,... 
Via Benzinga
News headline image
Wednesdays With Wedbush: 3 Smid-Cap Biotech Stock Picks ↗
Since the coronavirus pandemic began in early 2020, the FDA's plate has been full with reviews of COVID-19 vaccines and treatments. That has put the approval of many... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2022 ↗
Upgrades For Douglas Emmett Inc (NYSE:DEI), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. For the fourth quarter, Douglas Emmett had an EPS of $0.48,... 
Via Benzinga
News headline image
Earnings Outlook For IVERIC bio ↗
IVERIC bio (NASDAQ:ISEE) is set to give its latest quarterly earnings report on Thursday, 2022-02-24. Here's what investors need to know before the announcement. Analysts estimate... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
Gainers Avenue Therapeutics (NASDAQ:ATXI... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly's Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adcom Rules That Lilly May Have To Conduct Additional Studies For Co-... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Gainers Avenue Therapeutics (NASDAQ:ATXI)... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For February 7, 2022 ↗
Upgrades For Enova International Inc (NYSE:ENVA), Maxim Group upgraded the previous rating of Hold to Buy. For the fourth quarter, Enova International had an EPS of $1.61,... 
Via Benzinga
News headline image
Futures Tread Water Amid Peripheral Bond Rout As Key CPI Print Looms ↗
U.S. index futures swung around in a volatile, illiquid overnight session, and at last check were flat despite traders' concerns about growing fireworks in the European bond market where Italian and... 
Via Talk Markets
News headline image
7 A-Rated Biotechs to Buy for the Long Run ↗
The one thing the pandemic has shown us is biotechs are changing the way we treat diseases. These A-rated biotechs are great examples. 
Via InvestorPlace
News headline image
10 Biggest Price Target Changes For Wednesday ↗
Needham raised DoorDash, Inc. (NASDAQ:DASH) pric... 
Via Benzinga
News headline image
IVERIC bio, Inc. (ISEE) Q3 2021 Earnings Call Transcript ↗
ISEE earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.